UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (11), p.1460-1464

2021

Volltextzugriff (PDF)

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016-09, Vol.99, p.79-87

2016

Volltextzugriff (PDF)

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR -Mutant NSCLC

Clinical cancer research, 2018-12, Vol.24 (24), p.6195-6203

2018

Volltextzugriff (PDF)

Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer

Clinical cancer research, 2017-02, Vol.23 (3), p.618-622

2017

Volltextzugriff (PDF)

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

Nature communications, 2018-08, Vol.9 (1), p.3114-8, Article 3114

2018

Volltextzugriff (PDF)

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2234-2245

2017

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2018-07, Vol.6 (1), p.75-75, Article 75

2018

Volltextzugriff (PDF)

Targeted Therapy and Immunotherapy in the Treatment of Non–Small Cell Lung Cancer

The Radiologic clinics of North America, 2018-05, Vol.56 (3), p.485-495

2018

Volltextzugriff (PDF)

Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer

Clinical lung cancer, 2022-01, Vol.23 (1), p.72-81

2022

Volltextzugriff (PDF)

Gene expression profiling predicts the development of oral cancer

Cancer prevention research (Philadelphia, Pa.), 2011-02, Vol.4 (2), p.218-229

2011

Volltextzugriff (PDF)

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002973

2021

Volltextzugriff (PDF)

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer

Clinical cancer research, 2019-08, Vol.25 (15), p.4691-4700

2019

Volltextzugriff (PDF)

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

Clinical cancer research, 2016-07, Vol.22 (14), p.3630-3642

2016

Volltextzugriff (PDF)

An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer

Translational oncology, 2019-06, Vol.12 (6), p.836-845

2019

Volltextzugriff (PDF)

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

The New England journal of medicine, 2017-02, Vol.376 (7), p.629-640

2017

Volltextzugriff (PDF)

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2702-2709

2018

Volltextzugriff (PDF)

Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy

Journal of clinical oncology, 2009-02, Vol.27 (4), p.599-604

2009

Volltextzugriff (PDF)

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

Nature communications, 2019-01, Vol.10 (1), p.552-552, Article 552

2019

Volltextzugriff (PDF)

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

Clinical cancer research, 2008-04, Vol.14 (7), p.2095-2101

2008

Volltextzugriff (PDF)

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.553-559

2019

Volltextzugriff (PDF)

Postoperative Radiotherapy for Maxillary Sinus Cancer: Long-Term Outcomes and Toxicities of Treatment

International journal of radiation oncology, biology, physics, 2007-07, Vol.68 (3), p.719-730

2007

Volltextzugriff (PDF)

Optimizing biomarkers and endpoints in oral cancer chemoprevention trials

Cancer prevention research (Philadelphia, Pa.), 2013-05, Vol.6 (5), p.375-378

2013

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(269)
Buchkapitel
(1)

Sprache

Englisch
(269)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(137)
Humans
(123)
Oncology
(123)
Female
(76)
Male
(74)
Middle Aged
(64)
Aged
(60)
Lung Neoplasms - Drug Therapy
(54)
Adult
(51)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(47)
Lung Cancer
(36)
Treatment Outcome
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Aged, 80 And Over
(31)
Lung Neoplasms - Genetics
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Respiratory System
(28)
Lung Neoplasms - Pathology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(67)
Journal Of Thoracic Oncology
(44)
Clinical Cancer Research
(20)
Cancer Research
(18)
Cancer
(13)
Cancer Prevention Research
(11)
Clinical Lung Cancer
(10)
Jnci : Journal Of The National Cancer Institute
(7)
Lung Cancer
(6)
Cancer Discovery
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR -Mutant NSCLC

Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Targeted Therapy and Immunotherapy in the Treatment of Non–Small Cell Lung Cancer

Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer

Gene expression profiling predicts the development of oral cancer

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Postoperative Radiotherapy for Maxillary Sinus Cancer: Long-Term Outcomes and Toxicities of Treatment

Optimizing biomarkers and endpoints in oral cancer chemoprevention trials

Suchergebnisse filtern